We are live on
!
Find out more
CCM
Copernicus Capital Management Portfolio holdings
AUM
$8.26M
1-Year Est. Return
37.91%
This Fund
S&P 500
This Quarter
Est. Return
+4.36%
1 Year Est. Return
+37.91%
3 Year Est. Return
+125.98%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$134M
AUM Growth
–
Cap. Flow
+$132M
Cap. Flow
% of AUM
98.59%
Top 10 Holdings %
Top 10 Hldgs %
62.1%
Holding
23
New
23
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Illumina
ILMN
|
+$9.98M |
| 2 |
AET
Aetna Inc
AET
|
+$9.84M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$9.22M |
| 4 |
HOLX
Hologic
HOLX
|
+$8.78M |
| 5 |
DaVita
DVA
|
+$8.67M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 79.38% |
| 2 | Financials | 7.69% |
| 3 | Consumer Discretionary | 2.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AET
1
DELISTED
Aetna Inc
AET
| $10.3M | 7.69% |
+57,291
| New | +$9.84M |
|
|
2
Illumina
ILMN
$29.8B
| $10.3M | 7.68% |
+48,522
| New | +$9.98M |
|
|
3
DaVita
DVA
$15B
| $10.2M | 7.57% |
+140,800
| New | +$8.67M |
|
|
HOLX
4
DELISTED
Hologic
HOLX
| $9.41M | 7.01% |
+220,240
| New | +$8.78M |
|
|
5
Vertex Pharmaceuticals
VRTX
$120B
| $9.34M | 6.95% |
+62,291
| New | +$9.22M |
|
6
Intuitive Surgical
ISRG
$119B
| $8.03M | 5.98% |
+66,000
| New | +$8.26M |
|
|
FOLD
7
DELISTED
Amicus Therapeutics
FOLD
| $6.58M | 4.9% |
+457,617
| New | +$6.29M |
|
8
Edwards Lifesciences
EW
$48.3B
| $6.54M | 4.87% |
+174,030
| New | +$6.39M |
|
9
Puma Biotechnology
PBYI
$408M
| $6.5M | 4.84% |
+65,742
| New | +$7.36M |
|
10
Stryker
SYK
$122B
| $6.19M | 4.61% |
+40,000
| New | +$6.1M |
|
|
EVHC
11
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $6.08M | 4.53% |
+176,000
| New | +$6.16M |
|
12
Biogen
BIIB
$29.6B
| $5.84M | 4.35% |
+18,321
| New | +$5.88M |
|
|
TSRO
13
DELISTED
TESARO, Inc.
TSRO
| $5.3M | 3.95% |
+64,000
| New | +$6.27M |
|
|
AERI
14
DELISTED
Aerie Pharmaceuticals
AERI
| $4.67M | 3.48% |
+78,132
| New | +$4.74M |
|
15
Zoetis
ZTS
$31.3B
| $4.09M | 3.04% |
+56,718
| New | +$3.9M |
|
|
NUVA
16
DELISTED
NuVasive, Inc.
NUVA
| $4.05M | 3.02% |
+69,280
| New | +$3.93M |
|
|
17
CALL
Puma Biotechnology
PBYI
$408M
| $3.66M | 2.72% |
+37,000
| New | +$4.14M |
|
18
Molina Healthcare
MOH
$10.5B
| $3.6M | 2.68% |
+47,000
| New | +$3.39M |
|
19
Service Corp International
SCI
$10.9B
| $3.53M | 2.63% |
+94,494
| New | +$3.38M |
|
|
PTLA
20
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $2.88M | 2.14% |
+59,149
| New | +$2.99M |
|
|
ADMS
21
DELISTED
Adamas Pharmaceuticals
ADMS
| $2.63M | 1.96% |
+77,517
| New | +$2.16M |
|
|
CLVS
22
DELISTED
Clovis Oncology, Inc.
CLVS
| $2.48M | 1.85% |
+36,544
| New | +$2.56M |
|
|
BEAT
23
DELISTED
BioTelemetry, Inc.
BEAT
| $2.09M | 1.56% |
+70,000
| New | +$2.03M |
|
Similar funds
AAM
IR
YEPV
LC
MA
IFC
PVMCV
ARTA
Copernicus Capital Management's Q4 2017 Portfolio in Review
Q4 2017 is the first quarter with a 13F filing on record for Copernicus Capital Management, which disclosed 23 positions worth $134M. Its ten largest holdings account for 62% of the portfolio.
Its largest position is Illumina: 48,522 shares worth $10.3M.
By sector, the portfolio is most concentrated in Healthcare at 79% of assets, followed by Financials and Consumer Discretionary.
- Copernicus Capital Management's largest Q4 2017 buy was Illumina: 48,522 shares worth $10.3M.
- Copernicus Capital Management's ten largest holdings make up 62% of its $134M portfolio in Q4 2017.
- Copernicus Capital Management disclosed 23 positions in Q4 2017, its first 13F filing on record.
Based on Copernicus Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.